We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for ...

Objectives We aimed to synthesise the available data for the effect of stopping alpha-blocker therapy among men with lower urinary tract symptoms. The focus was on symptom, uroflowmetry and quality of ...

New intake of systemic selective beta-blockers alone appears to be associated with IOP reductions, whereas discontinuation may increase it. Any changes after starting statins or calcium channel ...

Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated ...

Alpha blocker use in females with voiding difficulties and CKD linked to risk of fractures suggests a study published in the BMC Nephrology. Alpha blockers (ABs) are frequently prescribed to patients ...

Background: Guidelines generally recommend the use of beta-blockers in patients with heart failure (HF) and acute coronary syndrome (ACS). It has recently been suggested that non-selective ...

More recently, selective a-blocker medication have been successfully administered in patients ... The option of treatment with an uroselective alpha blocker terazosine was discussed including possible ...

It has been suggested that newer vasodilatory ß-blockers yield better glycemic control than older non-selective agents. The aim of this study was to evaluate the diabetogenicity of currently used ...